Skip to main content
Watch Insiders
AUPHHealthcare

Aurinia Pharmaceuticals Inc (AUPH) Insider Trading

In the last 90 days, 1 Aurinia Pharmaceuticals Inc (AUPH) insider reported no open-market purchases and 2 sales totaling $546,373. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 10, 2026Stephen P. RobertsonChief Legal OfficerSale11,939$15.95$190,427
Aug 21, 2026Stephen P. RobertsonChief Legal OfficerSale20,975$16.97$355,946
Jun 2, 2026Kevin TangChief Executive OfficerOpen Market Purchase814,606$15.29$12,455,244
Jun 2, 2026Tang Capital Management LLCCorporate insiderOpen Market Purchase814,606$15.29$12,455,244

Common questions

AUPH insider trading FAQ

Are AUPH insiders buying or selling?
Over the last 90 days, AUPH insiders were net sellers, reporting $0.00 of open-market purchases and $546,373 of sales.
When was the last AUPH insider purchase?
No open-market insider purchase of Aurinia Pharmaceuticals Inc stock was reported in the last 90 days.
Where does AUPH insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Aurinia Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.